Voyager Therapeutics, Inc.VYGRNASDAQ
LOADING
|||
Alerts
Want to monitor VYGR?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor VYGRWant to monitor VYGR?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor VYGRvoyager therapeutics is a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (cns). voyager is committed to advancing the field of aav (adeno-associated virus) gene therapy through innovation and investment in vector optimization and engineering, dosing techniques, as well as process development and production. the company’s initial pipeline is focused on cns diseases in dire need of effective new therapies, including parkinson’s disease, a monogenic form of amyotrophic lateral sclerosis (als), and friedreich’s ataxia.